Immune senescence: significance of the stromal microenvironment

Clinical and Experimental Immunology

Volumn 187, Issue 1, 2017, Pages 6-15

  Masters, A R ^a   Haynes, L ^a   Su, D M ^b   Palmer, D B ^c  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^c ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

aging; cell differentiation; spleen and lymph nodes; stromal cells; thymus

Indexed keywords

BONE MARROW; CELL AGING; FOLLICULAR DENDRITIC CELL; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOSENESCENCE; LYMPH NODE; LYMPHOID ORGAN; MICROENVIRONMENT; PRIORITY JOURNAL; REJUVENATION; REVIEW; SPLEEN; STEM CELL NICHE; STROMA CELL; THYMUS; AGING; ANIMAL; IMMUNE SYSTEM; IMMUNOLOGY; REGENERATION; TUMOR MICROENVIRONMENT;

AGING; ANIMALS; CELLULAR MICROENVIRONMENT; HUMANS; IMMUNE SYSTEM; IMMUNOSENESCENCE; REGENERATION; STROMAL CELLS;

EID: 84988908555     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12851     Document Type: Review

References (133)

1. Anderson G, Jenkinson EJ. Lymphostromal interactions in thymic development and function. Nat Rev Immunol 2001; 1:31–40.
2. Junt T, Scandella E, Ludewig B. Form follows function: lymphoid tissue microarchitecture in antimicrobial immune defence. Nat Rev Immunol 2008; 8:764–75.
3. Mendelson A, Frenette PS. Hematopoietic stem cell niche maintenance during homeostasis and regeneration. Nat Med 2014; 20:833–46.
4. Aw D, Silva AB, Palmer DB. Immunosenescence: emerging challenges for an ageing population. Immunology 2007; 120:435–46.
5. Haynes L, Swain SL. Why aging T cells fail: implications for vaccination. Immunity 2006; 24:663–6.
6. Pawelec G, Akbar A, Caruso C et al. Human immunosenescence: is it infectious? Immunol Rev 2005; 205:257–68.
7. Chen WH, Kozlovsky BF, Effros RB et al. Vaccination in the elderly: an immunological perspective. Trends Immunol 2009; 30:351–9.
8. Cancro MP, Hao Y, Scholz JL et al. B cells and aging: molecules and mechanisms. Trends Immunol 2009; 30:313–8.
9. Akbar AN, Henson SM. Are senescence and exhaustion intertwined or unrelated processes that compromise immunity? Nat Rev Immunol 2011; 11:289–95.
10. Hazeldine J, Lord JM. Innate immunosenescence: underlying mechanisms and clinical relevance. Biogerontology 2015; 16:187–201.
11. Su DM, Aw D, Palmer DB. Immunosenescence: a product of the environment? Curr Opin Immunol 2013; 25:498–503.
12. Geiger H, Denkinger M, Schirmbeck R. Hematopoietic stem cell aging. Curr Opin Immunol 2014; 29:86–92.
13. Janzen V, Forkert R, Fleming HE et al. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a. Nature 2006; 443:421–6.
14. Rossi DJ, Bryder D, Seita J et al. Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age. Nature 2007; 447:725–9.
15. Nakamura-Ishizu A, Suda T. Aging of the hematopoietic stem cells niche. Int J Hematol 2014; 100:317–25.
16. Liang Y, Van Zant G, Szilvassy SJ. Effects of aging on the homing and engraftment of murine hematopoietic stem and progenitor cells. Blood 2005; 106:1479–87.
17. Sun L, Brown R, Chen S et al. Aging induced decline in T-lymphopoiesis is primarily dependent on status of progenitor niches in the bone marrow and thymus. Aging (Albany NY) 2012; 4:606–19.
18. Ergen AV, Boles NC, Goodell MA. Rantes/Ccl5 influences hematopoietic stem cell subtypes and causes myeloid skewing. Blood 2012; 119:2500–9.
19. Henry CJ, Casas-Selves M, Kim J et al. Aging-associated inflammation promotes selection for adaptive oncogenic events in B cell progenitors. J Clin Invest 2015; 125:4666–80.
20. Cheleuitte D, Mizuno S, Glowacki J. In vitro secretion of cytokines by human bone marrow: effects of age and estrogen status. J Clin Endocrinol Metab 1998; 83:2043–51.
21. Kfoury Y, Scadden DT. Mesenchymal cell contributions to the stem cell niche. Cell Stem Cell 2015; 16:239–53.
22. Bellantuono I, Aldahmash A, Kassem M. Aging of marrow stromal (skeletal) stem cells and their contribution to age-related bone loss. Biochim Biophys Acta 2009; 1792:364–70.
23. Baker N, Boyette LB, Tuan RS. Characterization of bone marrow-derived mesenchymal stem cells in aging. Bone 2015; 70:37–47.
24. Guang LG, Boskey AL, Zhu W. Age-related CXC chemokine receptor-4-deficiency impairs osteogenic differentiation potency of mouse bone marrow mesenchymal stromal stem cells. Int J Biochem Cell Biol 2013; 45:1813–20.
25. Zhu W, Liang G, Huang Z et al. Conditional inactivation of the CXCR4 receptor in osteoprecursors reduces postnatal bone formation due to impaired osteoblast development. J Biol Chem 2011; 286:26794–805.
26. Tuljapurkar SR, McGuire TR, Brusnahan SK et al. Changes in human bone marrow fat content associated with changes in hematopoietic stem cell numbers and cytokine levels with aging. J Anat 2011; 219:574–81.
27. Naveiras O, Nardi V, Wenzel PL et al. Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment. Nature 2009; 460:259–63.
28. Vas V, Wandhoff C, Dorr K et al. Contribution of an aged microenvironment to aging-associated myeloproliferative disease. PLoS One 2012; 7:e31523.
29. Vas V, Senger K, Dorr K et al. Aging of the microenvironment influences clonality in hematopoiesis. PLOS ONE 2012; 7:e42080.
30. Andre T, Meuleman N, Stamatopoulos B et al. Evidences of early senescence in multiple myeloma bone marrow mesenchymal stromal cells. PLOS ONE 2013; 8:e59756.
31. Reagan MR, Ghobrial IM. Multiple myeloma mesenchymal stem cells: characterization, origin, and tumor-promoting effects. Clin Cancer Res 2012; 18:342–9.
32. Zdzisinska B, Bojarska-Junak A, Dmoszynska A et al. Abnormal cytokine production by bone marrow stromal cells of multiple myeloma patients in response to RPMI8226 myeloma cells. Arch Immunol Ther Exp (Warsz) 2008; 56:207–21.
33. Garcia-Gomez A, Sanchez-Guijo F, Del Canizo MC et al. Multiple myeloma mesenchymal stromal cells: contribution to myeloma bone disease and therapeutics. World J Stem Cells 2014; 6:322–43.
34. Melchers F. Checkpoints that control B cell development. J Clin Invest 2015; 125:2203–10.
35. Stephan RP, Reilly CR, Witte PL. Impaired ability of bone marrow stromal cells to support B-lymphopoiesis with age. Blood 1998; 91:75–88.]
36. Labrie JE 3rd, Sah AP, Allman DM et al. Bone marrow microenvironmental changes underlie reduced RAG-mediated recombination and B cell generation in aged mice. J Exp Med 2004; 200:411–23.
37. Bilwani FA, Knight KL. Adipocyte-derived soluble factor(s) inhibits early stages of B lymphopoiesis. J Immunol 2012; 189:4379–86.
38. Chiu BC, Martin BE, Stolberg VR et al. The host environment is responsible for aging-related functional NK cell deficiency. J Immunol 2013; 191:4688–98.
39. Nair S, Fang M, Sigal LJ. The natural killer cell dysfunction of aged mice is due to the bone marrow stroma and is not restored by IL-15/IL-15Ralpha treatment. Aging Cell 2015; 14:180–90.
40. Shehata HM, Hoebe K, Chougnet CA. The aged nonhematopoietic environment impairs natural killer cell maturation and function. Aging Cell 2015; 14:191–9.
41. Shanley DP, Aw D, Manley NR et al. An evolutionary perspective on the mechanisms of immunosenescence. Trends Immunol 2009; 30:374–81.
42. Swain S, Clise-Dwyer K, Haynes L. Homeostasis and the age-associated defect of CD4 T cells. Semin Immunol 2005; 17:370–7.
43. Hale JS, Boursalian TE, Turk GL et al. Thymic output in aged mice. Proc Natl Acad Sci USA 2006; 103:8447–52.
44. Goronzy JJ, Lee WW, Weyand CM. Aging and T-cell diversity. Exp Gerontol 2007; 42:400–6.
45. Yager EJ, Ahmed M, Lanzer K et al. Age-associated decline in T cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virus. J Exp Med 2008; 205:711–23.
46. Coder B, Su DM. Thymic involution beyond T-cell insufficiency. Oncotarget 2015; 6:21777–8.
47. Chinn IK, Blackburn CC, Manley NR et al. Changes in primary lymphoid organs with aging. Semin Immunol 2012; 24:309–20.
48. Palmer DB. The effect of age on thymic function. Front Immunol 2013; 4:316.
49. Ortman CL, Dittmar KA, Witte PL et al. Molecular characterization of the mouse involuted thymus: aberrations in expression of transcription regulators in thymocyte and epithelial compartments. Int Immunol 2002; 14:813–22.
50. Griffith AV, Fallahi M, Venables T et al. Persistent degenerative changes in thymic organ function revealed by an inducible model of organ regrowth. Aging Cell 2012; 11:169–77.
51. Andrew D, Aspinall R. Age-associated thymic atrophy is linked to a decline in IL-7 production. Exp Gerontol 2002; 37:455–63.
52. Aw D, Taylor-Brown F, Cooper K et al. Phenotypical and morphological changes in the thymic microenvironment from ageing mice. Biogerontology 2009; 10:311–22.
53. Flores KG, Li J, Sempowski GD et al. Analysis of the human thymic perivascular space during aging. J Clin Invest 1999; 104:1031–9.
54. Gui J, Zhu X, Dohkan J et al. The aged thymus shows normal recruitment of lymphohematopoietic progenitors but has defects in thymic epithelial cells. Int Immunol 2007; 19:1201–11.
55. Mackall CL, Punt JA, Morgan P et al. Thymic function in young/old chimeras: substantial thymic T cell regenerative capacity despite irreversible age-associated thymic involution. Eur J Immunol 1998; 28:1886–93.
56. Zhu X, Gui J, Dohkan J et al. Lymphohematopoietic progenitors do not have a synchronized defect with age-related thymic involution. Aging Cell 2007; 6:663–72.
57. Min H, Montecino-Rodriguez E, Dorshkind K. Reduction in the developmental potential of intrathymic T cell progenitors with age. J Immunol 2004; 173:245–50.
58. Abbas AK, Benoist C, Bluestone JA et al. Regulatory T cells: recommendations to simplify the nomenclature. Nat Immunol 2013; 14:307–8.
59. Irla M, Hollander G, Reith W. Control of central self-tolerance induction by autoreactive CD4+ thymocytes. Trends Immunol 2010; 31:71–9.
60. Gascoigne NR, Palmer E. Signaling in thymic selection. Curr Opin Immunol 2011; 23:207–12.
61. Kronenberg M, Rudensky A. Regulation of immunity by self-reactive T cells. Nature 2005; 435:598–604.
62. Sakaguchi S, Ono M, Setoguchi R et al. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 2006; 212:8–27.
63. Wirnsberger G, Hinterberger M, Klein L. Regulatory T-cell differentiation versus clonal deletion of autoreactive thymocytes. Immunol Cell Biol 2011; 89:45–53.
64. Anderson MS, Venanzi ES, Chen Z et al. The cellular mechanism of Aire control of T cell tolerance. Immunity 2005; 23:227–39.
65. Anderson MS, Venanzi ES, Klein L et al. Projection of an immunological self shadow within the thymus by the aire protein. Science 2002; 298:1395–401.
66. Xia J, Wang H, Guo J et al. Age-related disruption of steady-state thymic medulla provokes autoimmune phenotype via perturbing negative selection. Aging Dis 2012; 3:248–59.
67. Thiault N, Darrigues J, Adoue V et al. Peripheral regulatory T lymphocytes recirculating to the thymus suppress the development of their precursors. Nat Immunol 2015; 16:628–34.
68. Lynch HE, Goldberg GL, Chidgey A et al. Thymic involution and immune reconstitution. Trends Immunol 2009; 30:366–73.
69. Min H, Montecino-Rodriguez E, Dorshkind K. Reassessing the role of growth hormone and sex steroids in thymic involution. Clin Immunol 2006; 118:117–23.]
70. Steinmann GG, Klaus B, Muller-Hermelink HK. The involution of the ageing human thymic epithelium is independent of puberty. A morphometric study. Scand J Immunol 1985; 22:563–75.
71. Aw D, Palmer DB. It's not all equal: a multiphasic theory of thymic involution. Biogerontology 2012; 13:77–81.
72. Olsen NJ, Olson G, Viselli SM et al. Androgen receptors in thymic epithelium modulate thymus size and thymocyte development. Endocrinology 2001; 142:1278–83.
73. Griffith AV, Venables T, Shi J et al. Metabolic damage and premature thymus aging caused by stromal catalase deficiency. Cell Rep 2015; 12:1071–9.
74. Richardson RB, Allan DS, Le Y. Greater organ involution in highly proliferative tissues associated with the early onset and acceleration of ageing in humans. Exp Gerontol 2014; 55:80–91.
75. Nehls M, Pfeifer D, Schorpp M et al. New member of the winged-helix protein family disrupted in mouse and rat nude mutations. Nature 1994; 372:103–7.
76. Reis MD, Csomos K, Dias LP et al. Decline of FOXN1 gene expression in human thymus correlates with age: possible epigenetic regulation. Immun Ageing 2015; 12:18.
77. O'Neill KE, Bredenkamp N, Tischner C et al. Foxn1 Is dynamically regulated in thymic epithelial cells during embryogenesis and at the onset of thymic involution. PLOS ONE 2016; 11:e0151666.
78. Chen L, Xiao S, Manley NR. Foxn1 is required to maintain the postnatal thymic microenvironment in a dosage-sensitive manner. Blood 2009; 113:567–74.
79. Cheng L, Guo J, Sun L et al. Postnatal tissue-specific disruption of transcription factor FoxN1 triggers acute thymic atrophy. J Biol Chem 2010; 285:5836–47.
80. Sun L, Guo J, Brown R et al. Declining expression of a single epithelial cell-autonomous gene accelerates age-related thymic involution. Aging Cell 2010; 9:347–57.
81. Zook EC, Krishack PA, Zhang S et al. Overexpression of Foxn1 attenuates age-associated thymic involution and prevents the expansion of peripheral CD4 memory T cells. Blood 2011; 118:5723–31.
82. Bredenkamp N, Nowell CS, Blackburn CC. Regeneration of the aged thymus by a single transcription factor. Development 2014; 141:1627–37.
83. Garfin PM, Min D, Bryson JL et al. Inactivation of the RB family prevents thymus involution and promotes thymic function by direct control of Foxn1 expression. J Exp Med 2013; 210:1087–97.
84. Yang H, Youm YH, Dixit VD. Inhibition of thymic adipogenesis by caloric restriction is coupled with reduction in age-related thymic involution. J Immunol 2009; 183:3040–52.
85. Aw D, Silva AB, Maddick M et al. Architectural changes in the thymus of aging mice. Aging Cell 2008; 7:158–67.
86. Youm YH, Yang H, Sun Y et al. Deficient ghrelin receptor-mediated signaling compromises thymic stromal cell microenvironment by accelerating thymic adiposity. J Biol Chem 2009; 284:7068–77.
87. Yang H, Youm YH, Vandanmagsar B et al. Obesity accelerates thymic aging. Blood 2009; 114:3803–12.
88. Youm YH, Horvath TL, Mangelsdorf DJ et al. Prolongevity hormone FGF21 protects against immune senescence by delaying age-related thymic involution. Proc Natl Acad Sci USA 2016; 113:1026–31.
89. Sempowski GD, Hale LP, Sundy JS et al. Leukemia inhibitory factor, oncostatin M, IL-6, and stem cell factor mRNA expression in human thymus increases with age and is associated with thymic atrophy. J Immunol 2000; 164:2180–7.
90. Campisi J, Andersen JK, Kapahi P et al. Cellular senescence: a link between cancer and age-related degenerative disease? Semin Cancer Biol 2011; 21:354–9.
91. van Deursen JM. The role of senescent cells in ageing. Nature 2014; 509:439–46.
92. Aspinall R, Pido-Lopez J, Imami N et al. Old rhesus macaques treated with interleukin-7 show increased TREC levels and respond well to influenza vaccination. Rejuvenation Res 2007; 10:5–17.
93. Min D, Panoskaltsis-Mortari A, Kuro OM, et al. Sustained thymopoiesis and improvement in functional immunity induced by exogenous KGF administration in murine models of aging. Blood 2007; 109:2529–37.
94. Dudakov JA, Hanash AM, Jenq RR et al. Interleukin-22 drives endogenous thymic regeneration in mice. Science 2012; 336:91–5.
95. Dixit VD, Yang H, Sun Y et al. Ghrelin promotes thymopoiesis during aging. J Clin Invest 2007; 117:2778–90.
96. Aw D, Hilliard L, Nishikawa Y et al. Disorganization of the splenic microanatomy in ageing mice. Immunology 2016; 148:92–101.
97. Lefebvre JS, Maue AC, Eaton SM et al. The aged microenvironment contributes to the age-related functional defects of CD4 T cells in mice. Aging Cell 2012; 11:732–40.
98. Wols HA, Johnson KM, Ippolito JA et al. Migration of immature and mature B cells in the aged microenvironment. Immunology 2010; 129:278–90.
99. Fletcher AL, Acton SE, Knoblich K. Lymph node fibroblastic reticular cells in health and disease. Nat Rev Immunol 2015.
100. Chang JE, Turley SJ. Stromal infrastructure of the lymph node and coordination of immunity. Trends Immunol 2015; 36:30–9.
101. Girard JP, Moussion C, Forster R. HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes. Nat Rev Immunol 2012; 12:762–73.
102. Betterman KL, Harvey NL. The lymphatic vasculature: development and role in shaping immunity. Immunol Rev 2016; 271:276–92.
103. Akl TJ, Nagai T, Cote GL et al. Mesenteric lymph flow in adult and aged rats. Am J Physiol Heart Circ Physiol 2011; 301:H1828–40.
104. Chevalier S, Ferland G, Tuchweber B. Lymphatic absorption of retinol in young, mature, and old rats: influence of dietary restriction. FASEB J 1996; 10:1085–90.
105. Zolla V, Nizamutdinova IT, Scharf B et al. Aging-related anatomical and biochemical changes in lymphatic collectors impair lymph transport, fluid homeostasis, and pathogen clearance. Aging Cell 2015; 14:582–94.
106. Richner JM, Gmyrek GB, Govero J et al. Age-dependent cell trafficking defects in draining lymph nodes impair adaptive immunity and control of West Nile virus infection. PLOS Pathog 2015; 11:e1005027.
107. Mendonca GV, Pezarat-Correia P, Vaz JR et al. Impact of aging on endurance and neuromuscular physical performance: the role of vascular senescence. Sports Med 2016; DOI:10.1007/s40279-016-0596-8.
108. Malhotra D, Fletcher AL, Astarita J et al. Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks. Nat Immunol 2012; 13:499–510.
109. Cremasco V, Woodruff MC, Onder L et al. B cell homeostasis and follicle confines are governed by fibroblastic reticular cells. Nat Immunol 2014; 15:973–81.
110. Luther SA, Tang HL, Hyman PL et al. Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse. Proc Natl Acad Sci USA 2000; 97:12694–9.
111. Hadamitzky C, Spohr H, Debertin AS et al. Age-dependent histoarchitectural changes in human lymph nodes: an underestimated process with clinical relevance? J Anat 2010; 216:556–62.
112. Jiang Q, Li WQ, Aiello FB et al. Cell biology of IL-7, a key lymphotrophin. Cytokine Growth Factor Rev 2005; 16:513–33.
113. Link A, Vogt TK, Favre S et al. Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells. Nat Immunol 2007; 8:1255–65.
114. Mebius RE, Kraal G. Structure and function of the spleen. Nat Rev Immunol 2005; 5:606–16.
115. Bajenoff M, Glaichenhaus N, Germain RN. Fibroblastic reticular cells guide T lymphocyte entry into and migration within the splenic T cell zone. J Immunol 2008; 181:3947–54.
116. Qi H, Kastenmuller W, Germain RN. Spatiotemporal basis of innate and adaptive immunity in secondary lymphoid tissue. Annu Rev Cell Dev Biol 2014; 30:141–67.
117. Birjandi SZ, Ippolito JA, Ramadorai AK et al. Alterations in marginal zone macrophages and marginal zone B cells in old mice. J Immunol 2011; 186:3441–51.
118. Aydar Y, Balogh P, Tew JG et al. Follicular dendritic cells in aging, a ‘bottle-neck’ in the humoral immune response. Ageing Res Rev 2004; 3:15–29.
119. den Haan JM, Mebius RE, Kraal G. Stromal cells of the mouse spleen. Front Immunol 2012; 3:201.
120. Mueller SN, Germain RN. Stromal cell contributions to the homeostasis and functionality of the immune system. Nat Rev Immunol 2009; 9:618–29.
121. Bajenoff M, Egen JG, Koo LY et al. Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity 2006; 25:989–1001.
122. Nolte MA, Belien JA, Schadee-Eestermans I et al. A conduit system distributes chemokines and small blood-borne molecules through the splenic white pulp. J Exp Med 2003; 198:505–12.
123. Park J, Miyakawa T, Shiokawa A et al. Splenic stromal cells from aged mice produce higher levels of IL-6 compared to young mice. Mediat Inflamm 2014; 2014:826987.
124. Al'fonsova EV. Functional morphology of conjunctive tissue stroma of spleen in the age aspect. Adv Gerontol 2012; 25:415–21.
125. Rodrigues CJ, Sacchetti JC, Rodrigues AJ Jr. Age-related changes in the elastic fiber network of the human splenic capsule. Lymphology 1999; 32:64–9.
126. Wang C, Jurk D, Maddick M et al. DNA damage response and cellular senescence in tissues of aging mice. Aging Cell 2009; 8:311–23.
127. Wang X, Cho B, Suzuki K et al. Follicular dendritic cells help establish follicle identity and promote B cell retention in germinal centers. J Exp Med 2011; 208:2497–510.
128. Heesters BA, Myers RC, Carroll MC. Follicular dendritic cells: dynamic antigen libraries. Nat Rev Immunol 2014; 14:495–504.
129. Blomberg BB, Frasca D. Quantity, not quality, of antibody response decreased in the elderly. J Clin Invest 2011; 121:2981–3.
130. Sage PT, Tan CL, Freeman GJ et al. Defective TFH cell function and increased TFR cells contribute to defective antibody production in aging. Cell Rep 2015; 12:163–71.
131. Ansel KM, Ngo VN, Hyman PL et al. A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 2000; 406:309–14.
132. Aydar Y, Balogh P, Tew JG et al. Age-related depression of FDC accessory functions and CD21 ligand-mediated repair of co-stimulation. Eur J Immunol 2002; 32:2817–26.
133. Aydar Y, Balogh P, Tew JG et al. Altered regulation of Fc gamma RII on aged follicular dendritic cells correlates with immunoreceptor tyrosine-based inhibition motif signaling in B cells and reduced germinal center formation. J Immunol 2003; 171:5975–87.